Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Microfabrication for Drug Delivery.

Koch B, Rubino I, Quan FS, Yoo B, Choi HJ.

Materials (Basel). 2016 Aug 1;9(8). pii: E646. doi: 10.3390/ma9080646. Review.

2.

Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.

Jacob D, Ruffie C, Combredet C, Formaglio P, Amino R, Ménard R, Tangy F, Sala M.

Malar J. 2017 Jun 29;16(1):259. doi: 10.1186/s12936-017-1908-7.

3.

Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®.

Zhu D, Wu Y, McClellan H, Dai W, Rausch K, Jones D, Aebig J, Barnafo E, Butler B, Lambert L, Narum DL, Duffy PE.

Vaccine. 2017 May 31;35(24):3232-3238. doi: 10.1016/j.vaccine.2017.04.067. Epub 2017 May 4.

PMID:
28479180
4.

From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light Scattering.

Shardlow E, Mold M, Exley C.

Front Chem. 2017 Jan 9;4:48. doi: 10.3389/fchem.2016.00048. eCollection 2016.

5.

Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)3 adjuvant.

Luo M, Shao B, Yu JY, Liu T, Liang X, Lu L, Ye TH, He ZY, Xiao HY, Wei XW.

Cell Res. 2017 Apr;27(4):586-589. doi: 10.1038/cr.2017.14. Epub 2017 Jan 20. No abstract available.

6.

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.

Hayashi M, Aoshi T, Haseda Y, Kobiyama K, Wijaya E, Nakatsu N, Igarashi Y, Standley DM, Yamada H, Honda-Okubo Y, Hara H, Saito T, Takai T, Coban C, Petrovsky N, Ishii KJ.

EBioMedicine. 2017 Feb;15:127-136. doi: 10.1016/j.ebiom.2016.11.015. Epub 2016 Dec 1.

7.

Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.

Tam HH, Melo MB, Kang M, Pelet JM, Ruda VM, Foley MH, Hu JK, Kumari S, Crampton J, Baldeon AD, Sanders RW, Moore JP, Crotty S, Langer R, Anderson DG, Chakraborty AK, Irvine DJ.

Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6639-E6648. Epub 2016 Oct 4.

8.

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.

Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G.

PLoS One. 2016 Sep 13;11(9):e0162446. doi: 10.1371/journal.pone.0162446. eCollection 2016.

9.

Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.

Ruwona TB, Xu H, Li X, Taylor AN, Shi YC, Cui Z.

Vaccine. 2016 Jun 8;34(27):3059-3067. doi: 10.1016/j.vaccine.2016.04.081. Epub 2016 May 5.

10.

Silicone Oil Microdroplets Can Induce Antibody Responses Against Recombinant Murine Growth Hormone in Mice.

Chisholm CF, Baker AE, Soucie KR, Torres RM, Carpenter JF, Randolph TW.

J Pharm Sci. 2016 May;105(5):1623-1632. doi: 10.1016/j.xphs.2016.02.019. Epub 2016 Mar 25.

11.

Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

O'Brien VP, Hannan TJ, Nielsen HV, Hultgren SJ.

Microbiol Spectr. 2016 Feb;4(1). doi: 10.1128/microbiolspec.UTI-0013-2012. Review.

12.

Materials that harness and modulate the immune system.

Lewis JS, Roy K, Keselowsky BG.

MRS Bull. 2014 Jan 1;39(1):25-34.

13.

Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.

Salyer AC, Caruso G, Khetani KK, Fox LM, Malladi SS, David SA.

PLoS One. 2016 Feb 26;11(2):e0149848. doi: 10.1371/journal.pone.0149848. eCollection 2016.

14.

Automated Gravimetric Calibration to Optimize the Accuracy and Precision of TECAN Freedom EVO Liquid Handler.

Bessemans L, Jully V, de Raikem C, Albanese M, Moniotte N, Silversmet P, Lemoine D.

J Lab Autom. 2016 Oct;21(5):693-705. doi: 10.1177/2211068216632349. Epub 2016 Feb 23.

15.

Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity.

Martins KA, Cooper CL, Stronsky SM, Norris SL, Kwilas SA, Steffens JT, Benko JG, van Tongeren SA, Bavari S.

EBioMedicine. 2015 Nov 27;3:67-78. doi: 10.1016/j.ebiom.2015.11.041. eCollection 2016 Jan.

16.

Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model.

Gohar A, Abdeltawab NF, Fahmy A, Amin MA.

BMC Res Notes. 2016 Feb 9;9:80. doi: 10.1186/s13104-016-1891-z.

17.

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Petrovsky N.

Drug Saf. 2015 Nov;38(11):1059-74. doi: 10.1007/s40264-015-0350-4. Review.

18.

Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit.

Lu W, Qiu L, Yan Z, Lin Z, Cao M, Hu C, Wang Z, Wang J, Yu Y, Cheng X, Cao P, Li R.

Oncotarget. 2015 Oct 27;6(33):34537-48. doi: 10.18632/oncotarget.5307.

19.

Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.

Beesu M, Caruso G, Salyer AC, Khetani KK, Sil D, Weerasinghe M, Tanji H, Ohto U, Shimizu T, David SA.

J Med Chem. 2015 Oct 8;58(19):7833-49. doi: 10.1021/acs.jmedchem.5b01087. Epub 2015 Sep 22.

20.

Efficient delivery of antigen to DCs using yeast-derived microparticles.

Pan Y, Li X, Kang T, Meng H, Chen Z, Yang L, Wu Y, Wei Y, Gou M.

Sci Rep. 2015 May 29;5:10687. doi: 10.1038/srep10687.

Supplemental Content

Support Center